Brief: MiMedx Q4 Sales USD 118.095 Million Vs. IBES Estimate USD 106.8 Million
25/02/2026 21:01
Feb 25 (Reuters) - MiMedx Q4 adjusted EBITDA USD 29.375 million vs. IBES estimate USD 25.9 million. Q4 gross profit USD 99.04 million Q4 net income USD 15.191 million Q4 operating income USD 21.078 million outlook FY sales USD 340-360 million
Recent news on MiMedx
See all newsMiMedx Q1 sales fall 33%, miss estimates, cuts 2026 outlook
Brief: MiMedx Q1 Sales USD 58.991 Million Vs. IBES Estimate USD 65 Million
MiMedx beats Q4 sales estimates; announces $100 mln share buyback
Brief: MiMedx Q4 Sales USD 118.095 Million Vs. IBES Estimate USD 106.8 Million
MiMedx Q3 net sales beat estimates